3Ponder BA. The phenotypes associated with ret mutations in multiple endocrine neoplasias type 2 syndrome [ J ]. Cancer Res, 1999, 59 ( 7 ) :S1736-S1742,
4Andreas M, Ulrich S, Hans - Jurgen H, et al. Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level[J ]. The J Endocrinol Metabol, 2005, 90(4) : 2029-2034.
5Hinze R, Holzhausen HJ, Gmm O, et al. Primary hereditary medullary thyroid carcinoma C - cell morphology and correlation with preoperative ealcitonin level[J]. Virchows Arch, 1998, 433(3):203-208.
7Dralle H, Gmm O, Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma:German and Austrian experience[J]. World J Surg, 1998, 22(7) :744-751.
3Frankenthaler RA, Sellin RV, Cangir A, et al. lymph node metastasis from papillary-follicular thyroid carcinoma in young patients. Am J Surg,1990,160: 341-343.
4Mirallie E, Visset J, Sagan C, et al . Localization of cervical node metastasis of papillary thyroid carcinoma. World J Surg, 1999,23 : 970-973.
5van Heerden JA, Grant CS, Gharib H, et al. Long-term course of patients with persistent hypezcalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma.Ann Surg, 1990,212:395-400.
6Marzano LA, Porcelli A, Biondi B,et al. Surgical management and followup of medullary thyroid carcinoma.J Surg Oncol, 1995,59:162-168.
7Tisell LE, Hansson G, Jansson S, et al. Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Smgery, 1986,99:60-66.
8Scopsi L, Sampietro G, Boracchi P, et al. Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid: a retrospective study of 109 consecutive patients. Cancer, 1996,78:2173-2183.
9Fuchshuber PR, Loree TR, Hicks WL Jr, et al. Medullary carcinoma of the thyroid: prognostic factors and treatment recommendations. Ann Surg Oncol, 1998,5:81-86.
10Modigliani E, Cohen R, Campos JM, et al. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: result in 899 patients. The GETC Study Group. Groupe d' etude des tumeurs a calcitonine. Clin Endocrino; 1998.48:265-273.
7Andreas M,Ulrich S,Hans-Jurgen H,et al.Prospects Of remission in medullary thyroid carcinoma according to basal calcitonin level[J].The J Endocrinol Metab ol,2005;90(4):2029-2034.
8Rausch P,Nowels K,Jeffrey RB Jr.Ultrasonographically guided thyroid biopsy:a rewiew with emphasis on technique[J].J Ultrasound Med,2001,20(1):79-85.
9Corsella SM,Lovicu RM,Migneco MG,et al.Diagnostic approach,genetic screening and Prognostic factors of medullary thyroid carcinoma[J].Rays,2002,25(2):257-266.
10Brunt LM,Wells SA Jr.Advances in the diagnosis and treatment of medullary thyroid carcinoma[J].Surg Clin North Am,1987,67(2):263-279.
